Migraine Clinical Trials in Philadelphia

Showing 1-20 of 105 trials

MMA Embolization for Refractory Chronic Migraine

NCT06735833

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Migraine

Cerenovus, Part of DePuy Synthes Products, Inc.70 participantsStarted Apr 2025

Phoenix, Arizona, United States • Walnut Creek, California, United States • Hartford, Connecticut, United States +6 more locations

RECRUITINGPhase 3< 1 mile

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT06641466

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience menstrual migraine attacks.

Menstrual Migraine

Pfizer723 participantsStarted Mar 2025

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +119 more locations

MMA Embolization for Refractory Chronic Migraine

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Migraine Trials in Other Cities

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Initiating Early Control of Migraine Pain and Associated Symptoms

Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

Other Conditions in Philadelphia